NCT02291809View on ClinicalTrials.gov

REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study

PHASE2UnknownINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
HIV/AIDS
Interventions
BIOLOGICAL

REMUNE

Inoculation of HIV-1 Virus via Vaccination of Whole Killed GP120 Depleted P24 Antigen Vaccine

Trial Locations (1)

92101

Clinical Site TBA, San Diego

Sponsors
All Listed Sponsors
lead

Immune Response BioPharma, Inc.

INDUSTRY